Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iscador P versus oral etoposide after second relapse surgery in spindle-cell bone sarcoma
2006-002676-18Phase 4Completed
- Sponsor
- Weleda
- Start
- Aug 2007
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in osteosarcoma (OS) and bone cancer comparing Iscador P with Oral etoposide (2 arms). Primary endpoint: Post-relapse disease-free survival rate. Started Aug 2007; status: completed.
02
Drugs
Iscador Petoposide
03
Conditions
osteosarcoma (OS)bone cancer
Beyond the preview
Go deeper on 2006-002676-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002676-18.